New Robotic Microfluidic Platform Brings AI to Lipid Nanoparticle Design
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery vehicles behind mRNA therapies like the COVID-19 vaccines, have been much more limited. Designing LNPs is especially challenging: Each formulation combines multiple lipid components whose ratios influence how the … Read more